Stock Events

Omnicell 

€24.2
2
+€0+0% Friday 19:41

统计数据

当日最高
24.4
当日最低
24.2
52周最高
-
52周最低
-
成交量
0
平均成交量
-
市值
1.22B
市盈率
-57.97
股息收益率
-
股息
-

收益

2May已确认
Q3 2022
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
-0.09
0.27
0.64
1
预期每股收益
-0.09
实际每股收益
0.03

人们还关注

此列表基于关注OC9.F的Stock Events用户的观察列表。这不是投资建议。

竞争者

这个列表是基于最近市场事件的分析。这不是投资建议。

分析师评级

32平均价格目标
最高估值为 €38。
来自过去6个月内的 2 个评级。这不是投资建议。
买入
50%
持有
50%
卖出
0%

关于

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions; IV compounding robots; and inventory management software. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.
Show more...
首席执行官
Mr. Randall A. Lipps
员工
3590
国家
US
ISIN
US68213N1090
WKN
000632313

上市公司